| GenLei® Jintropin™ |
SOMATROPIN
Jintropin™ rhGH for injection
2.5, 4, 4.5, 10, 12 IU/vial |
|
| Jintropin™ somatropin is produced at GenSci by recombinant DNA technology in E.coli secretion expression system. Jintropin™ has the same amino acid sequence with 191 residues as the native human growth hormone produced in the human body. Jintropin™ is a highly purified preparation of hGH protein. |
|
| |
|
|
| |
First rhGH on the Chinese market, launched in 1998 |
|
| |
Over 25,000 patients treated in China, no unexpected side effects |
| |
Dominant brand of rhGH in China with 70% of market share |
| |
Advanced production technology with E.coli secretion expression system |
| |
The only 191-aa hGH made by secretion technology patented in China. |
| |
Largest production capability and best quality in Asia |
| |
Internal specification higher than that of Chinese Pharmacopoeia 2005 and European Pharmacopoeia 2005 |
| |
First approval in the world to treat burns |
| |
|
|
| |
|
|
|
back to top
